» Articles » PMID: 34988413

The Northeast Glucose Drift: Stratification of Post-breakfast Dysglycemia Among Predominantly Hispanic/Latino Adults At-risk or with Type 2 Diabetes

Overview
Specialty General Medicine
Date 2022 Jan 6
PMID 34988413
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is minimal experience in continuous glucose monitoring (CGM) among underserved racial/ethnic minority populations with or at risk of type 2 diabetes (T2D), and therefore a lack of CGM-driven insight for these individuals. We analyzed breakfast-related CGM profiles of free-living, predominantly Hispanic/Latino individuals at-risk of T2D, with pre-T2D, or with non-insulin treated T2D.

Methods: Starting February 2019, 119 participants in Santa Barbara, CA, USA, (93 female, 87% Hispanic/Latino [predominantly Mexican-American], age 54·4 [±12·1] years), stratified by HbA levels into (i) at-risk of T2D, (ii) with pre-T2D, and (iii) with non-insulin treated T2D, wore blinded CGMs for two weeks. We compared valid CGM profiles from 106 of these participants representing glucose response to breakfast using four parameters.

Findings: A "northeast drift" was observed in breakfast glucose responses comparing at-risk to pre-T2D to T2D participants. T2D participants had a significantly higher pre-breakfast glucose level, glucose rise, glucose incremental area under the curve (all  < 0·0001), and time to glucose peak ( < 0·05) compared to pre-T2D and at-risk participants. After adjusting for demographic and clinical covariates, pre-breakfast glucose and time to peak ( < 0·0001) were significantly associated with HbA. The model predicted HbA within (0·55 0·67)% of true laboratory HbA values.

Interpretation: For predominantly Hispanic/Latino adults, the average two-week breakfast glucose response shows a progression of dysglycemia from at-risk of T2D to pre-T2D to T2D. CGM-based breakfast metrics have the potential to predict HbA levels and monitor diabetes progression.

Funding: US Department of Agriculture (Grant #2018-33800-28404), a seed grant from the industry board fees of the NSF Engineering Research Center for Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) (Award #1648451), and the Elsevier foundation.

Citing Articles

Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial.

Moreira F, Reis C, Gallassi A, Moreira D, Welker A PLoS One. 2024; 19(10):e0311501.

PMID: 39383145 PMC: 11463819. DOI: 10.1371/journal.pone.0311501.


Estimating Breakfast Characteristics Using Continuous Glucose Monitoring and Machine Learning in Adults With or at Risk of Type 2 Diabetes.

Pai R, Barua S, Kim B, McDonald M, Wierzchowska-McNew R, Pai A J Diabetes Sci Technol. 2024; :19322968241274800.

PMID: 39311452 PMC: 11571632. DOI: 10.1177/19322968241274800.


A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring.

Barua S, Glantz N, Larez A, Bevier W, Sabharwal A, Kerr D Sci Rep. 2024; 14(1):2915.

PMID: 38316854 PMC: 10844336. DOI: 10.1038/s41598-024-52461-1.


Multimodal digital phenotyping of diet, physical activity, and glycemia in Hispanic/Latino adults with or at risk of type 2 diabetes.

Pai A, Santiago R, Glantz N, Bevier W, Barua S, Sabharwal A NPJ Digit Med. 2024; 7(1):7.

PMID: 38212415 PMC: 10784546. DOI: 10.1038/s41746-023-00985-7.


Temporal changes in bio-behavioral and glycemic outcomes following a produce prescription program among predominantly Hispanic/Latino adults with or at risk of type 2 diabetes.

Sato Imuro S, Sabharwal A, Conneely C, Glantz N, Bevier W, Barua S Heliyon. 2023; 9(8):e18440.

PMID: 37533982 PMC: 10391944. DOI: 10.1016/j.heliyon.2023.e18440.